PMS59 - Improvements In Productivity At Paid Work And Within Household, And Increased Participation In Daily Activities After 24 Weeks Of Certolizumab Pegol Treatment Of Axial Spondyloarthritis Patients, Including Patients With Ankylosing Spondylitis: Results Of A Phase 3 Double-Blind Randomized Placebo-Controlled Study

D Van Der Heijde,J Braun,M Rudwaleit,O Purcaru,A Kavanaugh

doi:10.1016/j.jval.2013.03.1159

PMS59 - Improvements In Productivity At Paid Work And Within Household, And Increased Participation In Daily Activities After 24 Weeks Of Certolizumab Pegol Treatment Of Axial Spondyloarthritis Patients, Including Patients With Ankylosing Spondylitis: Results Of A Phase 3 Double-Blind Randomized Placebo-Controlled Study

D Van Der Heijde, J Braun + Show 3 more

Open Access

https://doi.org/10.1016/j.jval.2013.03.1159

Copy DOI

Journal: Value in Health	Publication Date: May 1, 2013
License type: publisher-specific-oa

Affiliation: Rheumazentrum Ruhrgebiet, UCB Pharma (Belgium), Endokrinologikum, University of California, San Diego

#Improvements In Productivity #Participation In Daily Activities + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

PMS59 - Improvements In Productivity At Paid Work And Within Household, And Increased Participation In Daily Activities After 24 Weeks Of Certolizumab Pegol Treatment Of Axial Spondyloarthritis Patients, Including Patients With Ankylosing Spondylitis: Results Of A Phase 3 Double-Blind Randomized Placebo-Controlled Study

Full Text